Literature DB >> 25894274

A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Scott M Gordon1, Hailong Li2, Xiaoting Zhu2, Amy S Shah3, L Jason Lu2, W Sean Davidson1.   

Abstract

Plasma levels of low density lipoproteins (LDL) and high density lipoproteins (HDL) exhibit opposing associations with cardiovascular disease in human populations and mouse models have been heavily used to derive a mechanistic understanding of these relationships. In humans, recent mass spectrometry studies have revealed that the plasma lipoproteome is significantly more complex than originally appreciated. This is particularly true for HDL which contains some 90 distinct proteins, a majority of which play functional roles that go beyond those expected for simple lipid transport. Unfortunately, the mouse lipoproteome remains largely uncharacterized-a significant gap given the heavy reliance on the model. Using a gel filtration chromatography and mass spectrometry analysis that targets phospholipid-bound plasma proteins, we compared the mouse lipoproteome and its size distribution to a previous, identical human analysis. We identified 113 lipid associated proteins in the mouse. In general, the protein diversity in the LDL and HDL size ranges was similar in mice versus humans, though some distinct differences were noted. For the majority of proteins, the size distributions, that is, whether a given protein was associated with large versus small HDL particles, for example, were also similar between species. Again, however, there were clear differences exhibited by a minority of proteins that may reflect metabolic differences between species. Finally, by correlating the lipid and protein size profiles, we identified five proteins that closely track with the major HDL protein, apolipoprotein A-I across both species. Thus, mice have most of the minor proteins identified in human lipoproteins that play key roles in inflammation, innate immunity, proteolysis and its inhibition, and vitamin transport. This provides support for the continued use of the mouse as a model for many aspects of human lipoprotein metabolism.

Entities:  

Keywords:  apolipoprotein; high density lipoprotein; lipoprotein; mass spectrometry; mouse model; proteomics

Mesh:

Substances:

Year:  2015        PMID: 25894274      PMCID: PMC4712022          DOI: 10.1021/acs.jproteome.5b00213

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  38 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

Review 3.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

Review 4.  High-density lipoprotein subpopulations in pathologic conditions.

Authors:  Bela F Asztalos; Ernst J Schaefer
Journal:  Am J Cardiol       Date:  2003-04-03       Impact factor: 2.778

5.  Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma.

Authors:  G Kostner; P Alaupovic
Journal:  Biochemistry       Date:  1972-08-29       Impact factor: 3.162

6.  Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus.

Authors:  M C Camus; M J Chapman; P Forgez; P M Laplaud
Journal:  J Lipid Res       Date:  1983-09       Impact factor: 5.922

7.  Distribution of apolipoprotein A-IV between the lipoprotein and the lipoprotein-free fractions of rat plasma: possible role of lecithin:cholesterol acyltransferase.

Authors:  J G DeLamatre; C A Hoffmeier; A G Lacko; P S Roheim
Journal:  J Lipid Res       Date:  1983-12       Impact factor: 5.922

8.  Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.

Authors:  W Sean Davidson; R A Gangani D Silva; Sandrine Chantepie; William R Lagor; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-26       Impact factor: 8.311

9.  Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.

Authors:  Josep Julve; Joan Carles Escolà-Gil; Noemi Rotllan; Catherine Fiévet; Emmanuelle Vallez; Carolina de la Torre; Vicent Ribas; John H Sloan; Francisco Blanco-Vaca
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

10.  The redistribution and metabolism of iodinated apolipoprotein A-IV in rats.

Authors:  N H Fidge
Journal:  Biochim Biophys Acta       Date:  1980-07-14
View more
  37 in total

1.  Detecting the functional complexities between high-density lipoprotein mimetics.

Authors:  Yoshitaka J Sei; Jungho Ahn; Taeyoung Kim; Eunjung Shin; Angel J Santiago-Lopez; Seung Soon Jang; Noo Li Jeon; Young C Jang; YongTae Kim
Journal:  Biomaterials       Date:  2018-04-06       Impact factor: 12.479

Review 2.  Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

3.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

4.  Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns.

Authors:  Daniel Seung Kim; Anne U Jackson; Yatong K Li; Heather M Stringham; Johanna Kuusisto; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Charles F Burant; Veikko Salomaa; Michael Boehnke; Markku Laakso; Elizabeth K Speliotes
Journal:  J Lipid Res       Date:  2017-05-24       Impact factor: 5.922

Review 5.  Warming the mouse to model human diseases.

Authors:  Kirthana Ganeshan; Ajay Chawla
Journal:  Nat Rev Endocrinol       Date:  2017-05-12       Impact factor: 43.330

6.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Authors:  Melinde Wijers; Paolo Zanoni; Nalan Liv; Dyonne Y Vos; Michelle Y Jäckstein; Marieke Smit; Sanne Wilbrink; Justina C Wolters; Ydwine T van der Veen; Nicolette Huijkman; Daphne Dekker; Niels Kloosterhuis; Theo H van Dijk; Daniel D Billadeau; Folkert Kuipers; Judith Klumperman; Arnold von Eckardstein; Jan Albert Kuivenhoven; Bart van de Sluis
Journal:  JCI Insight       Date:  2019-06-06

7.  Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS.

Authors:  Edgar D Torres Fernandez; Alexandra M Huffman; Maryam Syed; Damian G Romero; Licy L Yanes Cardozo
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736

8.  Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma.

Authors:  Debi K Swertfeger; Hailong Li; Sandra Rebholz; Xiaoting Zhu; Amy S Shah; W Sean Davidson; Long J Lu
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

Review 9.  Systems Biology and Noninvasive Imaging of Atherosclerosis.

Authors:  Claudia Calcagno; Willem J M Mulder; Matthias Nahrendorf; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02       Impact factor: 8.311

10.  Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Patrick Tso; Catherine A Reardon; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteomics       Date:  2016-07-03       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.